Dr Megan Crumbaker is a medical oncologist specialising in GU oncology (prostate, kidney, bladder and testicular cancers). She is an investigator on multiple international clinical trials and has developed therapeutic studies that are currently underway at the Kinghorn. She completed a PhD in prostate cancer genomics at the Garvan Institute with the goal of translating this knowledge into clinical practice to improve the lives of patients with GU cancers.
She graduated from the University of Sydney and undertook medical oncology training at Royal North Shore hospital before pursuing fellowships in GU oncology at Westmead and St Vincent’s hospitals. She undertook a Beverley Alt Education Fellowship in 2018 at the Princess Margaret Cancer Centre in Toronto. Upon her return, she joined the Kinghorn Cancer Centre as a GU oncologist.
